Sanofi, Dabur Patent Dispute Over Eloxatin Survives
A federal judge has denied opposing summary judgment motions for plaintiff Sanofi-Aventis US LLC and defendants Fresenius Kabi Oncology PLC and Dabur Pharma Ltd. in an infringement suit over two patents...To view the full article, register now.
Already a subscriber? Click here to view full article